| Date Filed | Type | Description |
| 08/02/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/01/2023 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 9,621 options
@ $4.02, valued at
$38.7k
|
|
| 03/30/2022 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 109,323 options
@ $0.38, valued at
$41.5k
|
|
| 01/04/2022 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 12,000 options
@ $0.74, valued at
$8.9k
|
|
| 04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 12,000 options
@ $0.8, valued at
$9.6k
|
|
| 07/23/2020 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Exercised (in-or-at-the-money) 100,503 warrants
@ $0.87, valued at
$87.4k
|
|
| 06/17/2020 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on Provention Bio, Inc. |
| 06/09/2020 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Bought 5,000 shares
@ $0.92, valued at
$4.6k
|
|
| 05/29/2020 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Bought 5,000 shares
@ $0.9, valued at
$4.5k
|
|
| 05/26/2020 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Bought 10,000 shares
@ $0.78, valued at
$7.8k
|
|
| 04/13/2020 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 42,857 shares
@ $0 |
|
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/11/2019 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 100,503 shares
@ $0.87, valued at
$87.4k
Granted 89,585 options to buy
@ $0.9, valued at
$80.6k
Granted 100,503 warrants
@ $0.87, valued at
$87.4k
|
|
| 12/06/2019 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Acquired 342,000 shares
@ $0 |
|
| 09/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2019 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 5,000 shares
@ $8.44, valued at
$42.2k
|
|
| 09/25/2019 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 5,000 shares
@ $8.39, valued at
$42k
|
|
| 08/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2019 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 24,000 options to buy
@ $12.54, valued at
$301k
|
|
| 06/20/2019 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 10,000 shares
@ $10.96, valued at
$109.6k
|
|
| 06/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2019 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 25,000 shares
@ $12.16, valued at
$304k
|
|
| 03/27/2019 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 50,000 options
@ $3.09, valued at
$154.5k
|
|
| 01/04/2019 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Bought 10,000 shares
@ $4.81, valued at
$48.1k
|
|
| 01/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2019 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Bought 7,000 shares
@ $4.62, valued at
$32.3k
|
|
| 12/31/2018 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 10,000 shares
@ $1.76, valued at
$17.6k
|
|
| 12/28/2018 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 20,000 shares
@ $1.95, valued at
$39k
|
|
| 12/28/2018 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Bought 20,000 shares
@ $4.77, valued at
$95.4k
|
|
| 12/27/2018 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 17,270 shares
@ $1.92, valued at
$33.2k
|
|
| 12/26/2018 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 2,000 shares
@ $1.85, valued at
$3.7k
|
|
| 12/26/2018 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Bought 10,000 shares
@ $4.49, valued at
$44.9k
|
|
| 12/21/2018 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 5,000 shares
@ $1.96, valued at
$9.8k
|
|
|